Your browser doesn't support javascript.
loading
Basic Science and Public Policy: Informed Regulation for Nicotine and Tobacco Products.
Fowler, Christie D; Gipson, Cassandra D; Kleykamp, Bethea A; Rupprecht, Laura E; Harrell, Paul T; Rees, Vaughan W; Gould, Thomas J; Oliver, Jason; Bagdas, Deniz; Damaj, M Imad; Schmidt, Heath D; Duncan, Alexander; De Biasi, Mariella.
Afiliação
  • Fowler CD; Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA.
  • Gipson CD; Department of Psychology, Arizona State University, Tempe, AZ.
  • Kleykamp BA; PinneyAssociates, Bethesda, MD.
  • Rupprecht LE; Center for Neuroscience at the University of Pittsburgh, Pittsburgh, PA.
  • Harrell PT; Division of Community Health & Research, Department of Pediatrics, Eastern Virginia Medical School, Norfolk, VA.
  • Rees VW; Center for Global Tobacco Control, Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Gould TJ; Department of Biobehavioral Health, Pennsylvania State University, University Park, PA.
  • Oliver J; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC.
  • Bagdas D; Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA.
  • Damaj MI; Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA.
  • Schmidt HD; Department of Biobehavioral Health Sciences, School of Nursing, University of Pennsylvania, Philadelphia, PA.
  • Duncan A; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY.
  • De Biasi M; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Nicotine Tob Res ; 20(7): 789-799, 2018 06 07.
Article em En | MEDLINE | ID: mdl-29065200
ABSTRACT

Introduction:

Scientific discoveries over the past few decades have provided significant insight into the abuse liability and negative health consequences associated with tobacco and nicotine-containing products. While many of these advances have led to the development of policies and laws that regulate access to and formulations of these products, further research is critical to guide future regulatory efforts, especially as novel nicotine-containing products are introduced and selectively marketed to vulnerable populations.

Discussion:

In this narrative review, we provide an overview of the scientific findings that have impacted regulatory policy and discuss considerations for further translation of science into policy decisions. We propose that open, bidirectional communication between scientists and policy makers is essential to develop transformative preventive- and intervention-focused policies and programs to reduce appeal, abuse liability, and toxicity of the products.

Conclusions:

Through these types of interactions, collaborative efforts to inform and modify policy have the potential to significantly decrease the use of tobacco and alternative nicotine products and thus enhance health outcomes for individuals. Implications This work addresses current topics in the nicotine and tobacco research field to emphasize the importance of basic science research and provide examples of how it can be utilized to inform public policy. In addition to relaying current thoughts on the topic from experts in the field, the article encourages continued efforts and communication between basic scientists and policy officials.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Política Pública / Pesquisa Biomédica / Produtos do Tabaco / Nicotina Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Política Pública / Pesquisa Biomédica / Produtos do Tabaco / Nicotina Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article